Fabrice Branle Email & Phone Number | MD by training and graduated in Internal Medicine and Medical Oncology (Free University Brussels, Belgium) with 12 years of clinical practice in an academic center managing patients with Breast, Lung or CNS tumors. I joined Sanofi-Aventis, Belgium in 2005 as Medical Manager, supporting the medico-marketing strategy and realted activities related to Taxotere and Eloxatin. In 2007, I moved to R&D to support the Affiliate Clinical Research activities: evaluate the feasibility of corporate studies (oncology -diabetes and metabolism) in Belgium, medical support to site and Affiliate research staff (CRA, monitors). In parallel, I acted as Clinical Safety Officer within the SA Clinical Research Unit, with responsibilities in Belgium and the Netherlands with an overview of safety signal detected in patients treated in studies in both country, submission of safety related documents to Site, IRB/EC Involved a project to develop business synergies between Clinical Research Units based in Belgium and Netherlands I joined the Product Development Department of F.Hoffmann-La Roche Ltd. in Basel in March 2010. As Clinical Scientist working on T-DM1 , I was the medical lead of a large multicentric, multinational phase III study in HER2+ metastatic breast cancer and of a multicentric phase Ib/II study evaluating combinations of T-DM1 with chemotherapy and pertuzumab in locally advanced and metastatic Breast Cancer. In 2013, I joined Novartis, Oncology Global Development. Passionated about clinical research and motivated by the need to provide better therapeutic options to our cancer patients. Specialties: Medical Oncology - Drug Development - Clinical research

Fabrice Branle

MD by training and graduated in Internal Medicine and Medical Oncology (Free University Brussels, Be...
Novartis, c/o Novartis AG, Switzerland

*50 free lookup(s) per month.

No credit card required.

Fabrice Branle’s Email fabrice.branle@roche.com

Fabrice Branle’s Phone Numbers +1 212-830-****

Get FABRICE’s Phone Number (For Free)

Social Media

Fabrice Branle’s Location Novartis, c/o Novartis AG, Switzerland

Fabrice Branle’s Current Industry Novartis Oncology

Fabrice Branle’s Prior Industry Roche | Sanofi Aventis | Erasme University Hospital | Cliniques Du Sud | Erasme University Hospital Brussels

Not the Fabrice Branle you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Novartis Oncology

Global Program Clinical Head

2020-05-01 00:00:00 - Present

Roche

PD Medical Director

2010-03-01 00:00:00 - 2013-07-01 00:00:00

Sanofi Aventis

Medical Manager R&D Oncology - Clinical Safety Officer

2007-11-01 00:00:00 - 2010-03-01 00:00:00

Erasme University Hospital

Associated Head of Oncology Department

2003-10-01 00:00:00 - 2005-10-01 00:00:00

Cliniques Du Sud

Medical Oncologist

2002-10-01 00:00:00 - 2003-09-01 00:00:00

Erasme University Hospital Brussels

Resident in the Medical Oncology Department

2000-01-01 00:00:00 - 2002-09-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Fabrice Branle

Fabrice Branle is located at
Novartis, c/o Novartis AG, Switzerland

Fabrice Branle is a MD by training and graduated in Internal Medicine and Medical Oncology (Free University Brussels, Belgium) with 12 years of clinical practice in an academic center managing patients with Breast, Lung or CNS tumors. I joined Sanofi-Aventis, Belgium in 2005 as Medical Manager, supporting the medico-marketing strategy and realted activities related to Taxotere and Eloxatin. In 2007, I moved to R&D to support the Affiliate Clinical Research activities: evaluate the feasibility of corporate studies (oncology -diabetes and metabolism) in Belgium, medical support to site and Affiliate research staff (CRA, monitors). In parallel, I acted as Clinical Safety Officer within the SA Clinical Research Unit, with responsibilities in Belgium and the Netherlands with an overview of safety signal detected in patients treated in studies in both country, submission of safety related documents to Site, IRB/EC Involved a project to develop business synergies between Clinical Research Units based in Belgium and Netherlands I joined the Product Development Department of F.Hoffmann-La Roche Ltd. in Basel in March 2010. As Clinical Scientist working on T-DM1 , I was the medical lead of a large multicentric, multinational phase III study in HER2+ metastatic breast cancer and of a multicentric phase Ib/II study evaluating combinations of T-DM1 with chemotherapy and pertuzumab in locally advanced and metastatic Breast Cancer. In 2013, I joined Novartis, Oncology Global Development. Passionated about clinical research and motivated by the need to provide better therapeutic options to our cancer patients. Specialties: Medical Oncology - Drug Development - Clinical research - strong Team player.

Fabrice Branle currently works in the Novartis Oncology |

No Languages Available

Fabrice Branle has prior
experience in the following industries:
Roche | Sanofi Aventis | Erasme University Hospital | Cliniques Du Sud | Erasme University Hospital Brussels

Fabrice Branle has the following professional experience:
Novartis Oncology | Roche | Sanofi Aventis | Erasme University Hospital | Cliniques Du Sud | Erasme University Hospital Brussels